BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15498884)

  • 1. Structural determinants for g protein activation and selectivity in the second intracellular loop of the thyrotropin receptor.
    Neumann S; Krause G; Claus M; Paschke R
    Endocrinology; 2005 Jan; 146(1):477-85. PubMed ID: 15498884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants for G-protein activation and specificity in the third intracellular loop of the thyroid-stimulating hormone receptor.
    Claus M; Neumann S; Kleinau G; Krause G; Paschke R
    J Mol Med (Berl); 2006 Nov; 84(11):943-54. PubMed ID: 16955277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hydrophobic cluster in the center of the third extracellular loop is important for thyrotropin receptor signaling.
    Claus M; Jaeschke H; Kleinau G; Neumann S; Krause G; Paschke R
    Endocrinology; 2005 Dec; 146(12):5197-203. PubMed ID: 16150909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse functional motifs within the three intracellular loops of the CGRP1 receptor.
    Conner AC; Simms J; Conner MT; Wootten DL; Wheatley M; Poyner DR
    Biochemistry; 2006 Oct; 45(43):12976-85. PubMed ID: 17059214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The middle portion in the second cytoplasmic loop of the thyrotropin receptor plays a crucial role in adenylate cyclase activation.
    Kosugi S; Kohn LD; Akamizu T; Mori T
    Mol Endocrinol; 1994 Apr; 8(4):498-509. PubMed ID: 7914349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles and determinants of G-protein coupling by the rhodopsin-like thyrotropin receptor.
    Kleinau G; Jaeschke H; Worth CL; Mueller S; Gonzalez J; Paschke R; Krause G
    PLoS One; 2010 Mar; 5(3):e9745. PubMed ID: 20305779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hinge region of the TSH receptor stabilizes ligand binding and determines different signaling profiles of human and bovine TSH.
    Jaeschke H; Schaarschmidt J; Günther R; Mueller S
    Endocrinology; 2011 Oct; 152(10):3986-96. PubMed ID: 21846801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric mutagenesis of putative G-protein coupling domains of the alpha2A-adrenergic receptor. Localization of two redundant and fully competent gi coupling domains.
    Eason MG; Liggett SB
    J Biol Chem; 1996 May; 271(22):12826-32. PubMed ID: 8662784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New pathogenic thyrotropin receptor mutations decipher differentiated activity switching at a conserved helix 6 motif of family A GPCR.
    Biebermann H; Winkler F; Handke D; Teichmann A; Gerling B; Cameron F; Eichhorst J; Grüters A; Wiesner B; Kühnen P; Krude H; Kleinau G
    J Clin Endocrinol Metab; 2012 Feb; 97(2):E228-32. PubMed ID: 22112806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a region of the lutropin receptor extracellular domain near transmembrane helix 1 that is important in ligand-mediated signaling.
    Alvarez CA; Narayan P; Huang J; Puett D
    Endocrinology; 1999 Apr; 140(4):1775-82. PubMed ID: 10098515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Ser153 in ICL2 of the gonadotropin-releasing hormone (GnRH) receptor as a phosphorylation-independent site for inhibition of Gq coupling.
    Shacham S; Cheifetz MN; Fridkin M; Pawson AJ; Millar RP; Naor Z
    J Biol Chem; 2005 Aug; 280(32):28981-8. PubMed ID: 15964850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation.
    Neumann S; Claus M; Paschke R
    Eur J Endocrinol; 2005 Apr; 152(4):625-34. PubMed ID: 15817920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the amino terminus of the third intracellular loop in agonist-promoted downregulation of the alpha2A-adrenergic receptor.
    Jewell-Motz EA; Donnelly ET; Eason MG; Liggett SB
    Biochemistry; 1997 Jul; 36(29):8858-63. PubMed ID: 9220972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules.
    Führer D; Holzapfel HP; Wonerow P; Scherbaum WA; Paschke R
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3885-91. PubMed ID: 9360556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action.
    Wonerow P; Neumann S; Gudermann T; Paschke R
    J Mol Med (Berl); 2001 Dec; 79(12):707-21. PubMed ID: 11862314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A free carboxylate oxygen in the side chain of position 674 in transmembrane domain 7 is necessary for TSH receptor activation.
    Neumann S; Krause G; Chey S; Paschke R
    Mol Endocrinol; 2001 Aug; 15(8):1294-305. PubMed ID: 11463854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure/function relationships of a G-protein coupling pocket formed by the third intracellular loop of the m5 muscarinic receptor.
    Burstein ES; Spalding TA; Brann MR
    Biochemistry; 1998 Mar; 37(12):4052-8. PubMed ID: 9521726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor.
    Kosugi S; Ban T; Kohn LD
    Mol Endocrinol; 1993 Jan; 7(1):114-30. PubMed ID: 8095322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades.
    Parma J; Van Sande J; Swillens S; Tonacchera M; Dumont J; Vassart G
    Mol Endocrinol; 1995 Jun; 9(6):725-33. PubMed ID: 8592518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.